Webinars on demand

ArcherDX , now Invitae is a leading genomics company democratizing precision oncology.

Prostate cancer, the most frequently diagnosed cancer in 105 countries and the leading cause of death in 46 countries worldwide, is diagnosed by core needle biopsy.

clonoSEQ® Assay is a highly sensitive, specific, and standardized method for detecting and monitoring minimal residual disease (MRD).

Targeted NGS has been instrumental in driving our understanding of disease.

The Pathologist is delighted to introduce the Pathologists’ Assistants: Bridging the Gap Live Roundtable.

The use of genomic profiling for myeloid samples has accelerated in recent years due in part to increasing annotation of disease-associated biomarkers.

Region Skåne (Sweden) has implemented digital pathology in 4 labs across their enterprise.

Clinical trials are increasingly using liquid biopsy samples to complement or as an alternative to invasive tissue sample collections.

Targeting of the programmed cell death protein (PD-1)/ programmed death-ligand 1 (PD-L1) axis with checkpoint inhibitors has changed clinical practice in non-small cell lung cancer (NSCLC).

During this webinar, we will demonstrate a novel in situ detection strategy to better characterize the inflammatory burden during kidney and cardiac allograft rejection by targeting NK cells, T lymphocytes and macrophages.

Indica Labs is proud to introduce our HALO AP, state-of-the-art anatomic pathology software.

The acquisition and interpretation of digital, whole slide images (WSI) of microscope slides for diagnosis has potential to transform pathology practice.